TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
XCUR

Exicure Inc

Healthcare · Biotechnology

1.20$ -0.8% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement XCUR
Line item 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% – 100.0% – 100.0% –
424.0% 1,318.4% 134.6% 11,965.3% 1,089.4% 193.2% – 6.4% – 164.8% –
-324.0% -1,218.4% -34.6% 100.0% 100.0% -93.2% – 93.6% – 100.0% –
424.0% 1,318.4% 134.6% 11,965.3% 1,492.3% 193.2% – 68.6% – 0.0% –
226.5% 341.6% 72.5% 6,625.4% 661.5% 59.9% – 37.8% – 1,089.8% –
644.8% 1,660.0% 207.1% 18,590.7% 2,153.8% 59.9% – 99.9% – 2,546.4% –
-550.4% -1,560.0% -107.1% -18,490.7% -2,053.8% -153.1% – -6.4% – -2,446.4% –
0.0% 69.9% 8.2% 569.5% 60.6% 3.4% – 2.1% – 3.6% –
-550.7% -1,635.2% -113.3% -18,994.1% -2,029.6% -148.5% – -8.2% – -1,938.6% –
0.0% 64.6% 10.1% 358.5% 89.9% 5.4% – 0.7% – 1.6% –
-550.7% -1,635.2% -113.3% -18,994.1% -2,029.6% -148.5% – -9.0% – -1,940.2% –
-545.1% -1,548.0% -102.7% -18,394.9% -1,913.0% -136.3% – 0.3% – -1,770.2% –

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?